Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study.
about
Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysisThe Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerOverweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisSmoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study.Association between insulin resistance and breast carcinoma: a systematic review and meta-analysis.Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states.Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality.Risk factors of breast cancer: a systematic review and meta-analysis.Relationship between diabetes and risk of second primary contralateral breast cancer.Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.Serum glucose and risk of cancer: a meta-analysis.Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.Prediabetes and the risk of cancer: a meta-analysis.Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.Obesity, adipocytokines, and insulin resistance in breast cancer.Diabetes and breast cancer risk: a meta-analysis.Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adultsType 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer riskMetabolic profile of breast cancer in a population of women in southern Spain.Effect of oncological treatment on serum adipocytokine levels in patients with stage II-III breast cancer.Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.HDL-cholesterol and incidence of breast cancer in the ARIC cohort study.Cardiometabolic factors and breast cancer risk in U.S. black women.Differential effects of various progestogens on metabolic risk factors for breast cancer.Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.Obesity-related markers and breast cancer in CPS-II Nutrition Cohort.Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal womenPlasma C-peptide, mammographic breast density, and risk of invasive breast cancer.Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.Insulin resistance and hyperinsulinaemia in the development and progression of cancer.Insulinemia and the risk of breast cancer and its relapse.Poor early growth and excessive adult calorie intake independently and additively affect mitogenic signaling and increase mammary tumor susceptibility.Serum insulin and C-peptide concentration and breast cancer: a meta-analysis.Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.Altered metabolic profiles among older mothers with a history of preeclampsia.Metabolic factors and breast cancer risk in Korean women.The relationship between glucose metabolism disorders and malignant thyroid disease.
P2860
Q23920590-29E69BCE-8998-4E06-97A9-E1836D63BF31Q26777775-62A4FC2A-91F0-4B83-9879-55F0945F7BE8Q33351366-632215B2-232B-457F-A595-A04EFCAE8708Q33646525-8D0E607F-C50D-4FF0-B667-554B47F25C65Q33648093-7692C45E-3E93-4D8F-BA6A-3751FC17C4DEQ33727819-BD12E0DB-DB07-4169-B1E0-04D3D689F0E2Q33737320-11E02408-47DF-4BAA-B684-6023EC6EE8BAQ34078857-5E586C59-4625-40FB-902B-B88516908F85Q34315870-4B1935E5-3A1F-44D5-9954-1A9AEB7D7B57Q34346863-791C430A-8D61-4C8B-A745-600A5FEC0D6DQ34424031-52D0A5C3-B255-449D-97A7-A8B2606344D0Q34662854-C1BCE246-F2AB-435F-9D2B-894F09413E87Q35059999-3EA99FB7-6A3F-4974-9A67-DD910419466DQ35104958-0FD14607-CEB1-443C-BB8C-522D14E49715Q35246551-45C328F0-56CF-4D4A-891B-7863079BAC89Q35764308-533CA2CC-DFA1-4443-BCD1-8911B03EDF04Q35831676-68F2FD14-20CC-4E7F-B500-0EF17C0DF1CBQ36385281-0C03850D-73CB-4083-8B7E-993342737D59Q36519849-59B1C9D6-37E3-40AB-9B9E-EE4E21820C78Q36582700-63BCCBE0-F115-4F53-989B-76914C75C113Q36798413-2BBB3202-F5C4-47A6-8B75-3DF838DFA2EAQ36825139-97BC00BE-A23C-40F7-B630-E024A02AD724Q36918121-F17A1105-6DFB-4E96-B7F2-0D0A8379A7A1Q36918192-9675977C-D415-44D3-BCA8-8D59F30D386CQ36934633-6AD7113B-EF71-4778-A2F6-025B3CDA1CB0Q36942881-2DF1B7E6-DC65-4DFD-AD0F-ACECF5D502FCQ36974417-D66FA241-CD6B-4556-B3A6-A1EA896E9BF6Q37090766-6D232E61-1A26-402E-92C9-28F55FD21A89Q37172377-BF750699-DE79-4F2E-9542-431868BD4485Q37251624-2B693F04-F6D5-4849-AF3C-DB127BE550D6Q37259687-088F4266-E1E3-40EA-BCD6-5DB52601BACAQ37332118-A25B31A5-81D6-4641-8E1F-75092065B494Q37434345-286A9EC0-91C4-42B2-B956-2F2262D62E80Q38005770-EDE90213-7C35-4E46-9BCD-9E5F03A7D978Q42163631-291A902E-6C56-493C-91F4-6864F4ED18A0Q44072087-A8BCC38A-8EC5-4361-A2FB-0856FBC3E0D8Q44472863-93DD0B73-D8B4-4381-9E2C-0AD39921F347Q44908739-90C75012-1C8F-48E0-A7B6-246BFEF553EEQ46672039-24DB140A-1CE4-4E99-9B25-4671E94E571CQ47428276-913C94EB-C002-488C-AB28-A99CEBDA0A7B
P2860
Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Serum insulin and glucose leve ...... sis risk in communities study.
@en
type
label
Serum insulin and glucose leve ...... sis risk in communities study.
@en
prefLabel
Serum insulin and glucose leve ...... sis risk in communities study.
@en
P2093
P356
P1476
Serum insulin and glucose leve ...... sis risk in communities study.
@en
P2093
Aaron R Folsom
Anthony J Alberg
Eyal Shahar
Pamela J Mink
Wayne D Rosamond
P304
P356
10.1093/AJE/KWF050
P407
P577
2002-08-01T00:00:00Z